This web page provides information regarding the patent coverage of Inova Diagnostic's various products per the virtual patent marking provision (Section 16) of the America Invents Act and the virtual patent marking provisions in other jurisdictions.  Additional patents may be pending in the USA and in other international geographies.

 

Reagents

 

QUANTA Flash® β2 GP1 IgA

This product is covered by US patent #'s 7,745,146 and 8,338,117.

 

QUANTA Lite® β2 GP1 IgA

This product is covered by US patent #'s 7,745,146 and 8,338,117.

 

QUANTA Lite® β2 GP1 Screen

This product is covered by US patent #'s 7,745,146 and 8,338,117.

 

QUANTA Flash® HMGCR

This product is covered by US patent #’s 8,778,618, 9,335,326, and 9,506,924.

 

QUANTA Lite® HMGCR*

This product is covered by US patent #’s 8,778,618, 9,335,326, and 9,506,924.

 

NOVA Lite® HEp-2 Select®

This product is covered by US patent # 10,234,453.

 

QUANTA Flash® DFS70*

This product is covered by US patent # 10,234,453.

 

BIO-FLASH

This product is covered by US patent #’s 8,211,386, 8,476,080, 7,731,414, 8,550,697, 9,636,647, 7,731,899, 8,480,954, 9,523,699, 8,795,609, 8,728,413, 9,383,296, 8,916,108, 8,182,762, D560816, D621520, D565741, and D620603.

 

 

_{*Currently available outside the USA only.}